Understand disease biology—cell type to molecule. Now

Explore disease at cellular resolution

The Euretos Disease Atlas is an interactive research platform that maps diseases and their molecular interactions across organs, tissues, and cell types — giving you direct access to disease mechanisms, drivers, and candidate targets in one integrated view.

See all the evidence

For a translational researcher, disease biology is currently scattered across many databases, repositories, variant catalogs and pathway tools. Having all of this integrated in one platform changes what is possible. Questions that previously required a dedicated project can be explored, tested and answered independently.

View your data in the full context of disease

Upload your proprietary gene sets, variant data or expression experiments and see them immediately evaluated against the full integrated disease evidence base. Now explore mechanisms, identify drivers and prioritise candidates — with your data at the centre.

Understand disease biology from any angle

Whatever your starting point — a disease, a hypothesis, or your own data — explore every dimension to take you from initial question to defensible insight.

Disease pathophysiology

Map how disease disrupts biology across molecular, cellular and tissue levels

Anatomical context

Identify which tissues and cell types are implicated and how their biology is disrupted

Multiomic interactions

Trace genetic, expression and metabolic relationships within disease-relevant cell types

Disease drivers

Understand the genes and pathways actively driving disease

Target assessment

Evaluate efficacy, tractability, and safety.

Explainable scoring

Transparent evidence for every result.

Powered by curated and harmonised biomedical data

The Disease Atlas draws on one of the most comprehensive collections of biomedical literature, patents, experimental, clinical and real-world patient data — including 3,500 unique scRNA profiles. All data is harmonised across a single semantic (FAIR) framework, ensuring genuine interoperability and full traceability to source.

Make target decisions grounded in disease biology

Cell-type level evidence for every target
From disease insight to candidate shortlist - in a single session
Explainable scores backed by FAIR data
Your data contextualised in disease biology
Client review

Target Discovery

"We worked with Euretos to leverage their AI capabilities with the aim of finding new targets in two different indications. It was a real pleasure to work with them and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions, and swift responses and data delivery. In addition, we found their platform very useful for getting an overview of the different targets and for general queries."

Tau Benned-Jensen
Senior Research Scientist, H. Lundbeck A/S
Client review

Indication selection

“In this project, we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data-driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.”

Large European Pharma
Global Head
Client review

Target Assessment

"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day-to-day mission of bringing innovation into Teva."

Dr. Dana Bar-On
Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva Pharmaceuticals
Client review

Target Discovery

"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI platform is a mandatory input to our target discovery meetings."

Large European Biotech
Director Target Discovery
Client review

Indication Selection

"We find that the Euretos group was very easy to work and communicate with. The professional staff at Euretos did a great job extending their platform and capabilities to our advantage. Euretos helped us to extract meaningful information from a highly complex data domain, that we could build on internally."

Henriette Husum Bak-Jensen
Project Manager, Projects & Portfolio department, H. Lundbeck A/S
Client review

Target Assessment

"We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also, the team is well engaged, and had a very good understanding in the background of the project and our research question"

Large Japanese Pharma
Principal Scientist

Build detailed insights into the pathophysiology of disease

Explore how molecular, cellular and anatomical factors drive disease processes. Generate hypotheses grounded in the anatomical and cellular context that makes them defensible
SVG Graphic

Build detailed insights into the pathophysiology of disease

Explore how molecular, cellular and anatomical factors drive disease processes. Generate hypotheses grounded in the anatomical and cellular context that makes them defensible
SVG illustration
Get Started
SVG Graphic

Identify and prioritize biologically grounded therapeutic targets

Identify candidate targets by evaluating expression patterns, pathway roles and molecular interactions anchored to disease-specific tissues and cell types.

Identify and prioritize biologically grounded therapeutic targets

Identify candidate targets by evaluating expression patterns, pathway roles and molecular interactions anchored to disease-specific tissues and cell types.
SVG Graphic
Contact Us

Evaluate target relevance and actionability

Review the key characteristics of candidate targets like gene variants, dysregulation, druggability and clinical associations within their anatomical context and relevant disease drivers.
SVG Graphic

Evaluate target relevance and actionability

Review the key characteristics of candidate targets like gene variants, dysregulation, druggability and clinical associations within their anatomical context and relevant disease drivers.
SVG illustration
Get Started
SVG Graphic

Discover markers linked to disease mechanisms

Identify molecular markers associated with key disease drivers by evaluating expression patterns, variants, dysregulation and metabolic interactions across the cell types and anatomical contexts where they are expressed.

Discover markers linked to disease mechanisms

Identify molecular markers associated with key disease drivers by evaluating expression patterns, variants, dysregulation and metabolic interactions across the cell types and anatomical contexts where they are expressed.
SVG Graphic
Contact Us

Create thorough, evidence-backed scientific briefs

Access publication-backed evidence on targets, markers, diseases and molecular mechanisms and structure it into clear, reliable scientific communication.
SVG Graphic

Create thorough, evidence-backed scientific briefs

Access publication-backed evidence on targets, markers, diseases and molecular mechanisms and structure it into clear, reliable scientific communication.
SVG illustration
Get Started

Proven reliability for over a decade

Trusted by leading academic organisations, pharma and biotech for disease research and target discovery.
SVG Graphic

Data-driven disease insights